Angiopoietin-like protein 2 and angiopoietin-like protein 6 levels in patients with nonalcoholic fatty liver disease

Creative Commons License

Erkan G., Muratoglu S., Ercin U., Bilgihan A.

ARCHIVES OF MEDICAL SCIENCE, vol.14, no.4, pp.781-787, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 4
  • Publication Date: 2018
  • Doi Number: 10.5114/aoms.2016.61811
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.781-787
  • Keywords: nonalcoholic fatty liver disease, angiopoietin-like protein 2, angiopoietin-like protein 6, METABOLIC SYNDROME, INSULIN-RESISTANCE, GROWTH-FACTOR, SERUM-LEVELS, DIAGNOSIS, NONOBESE, OBESITY, EPIDEMIOLOGY, ADULTS
  • Gazi University Affiliated: Yes


Introduction: The aim of the current study was to examine the difference between patients detected with nonalcoholic fatty liver disease (NAFLD) and healthy subjects in terms of serum angiopoietin-like protein (ANGPTL) 2 and ANGPTL6 levels and to evaluate the correlation between ANGPTL2 and ANGPTL6 levels and liver enzyme levels, fasting glucose, lipid levels, and steatosis degree on ultrasonography (USG).